Artificial Intelligence (AI) is poised to transform clinical trials, from protocol design to patient recruitment, monitoring, and data analysis. But this transformation opportunity raises urgent questions: How do we ensure AI is used responsibly? What safeguards are necessary? And how can we make sure its impact benefits the entire ecosystem?
This cross-functional Working Group will bring together leaders from across the research ecosystem and anchor its work in the realities of clinical trial operations, especially at the site level. The group will explore practical, real-world applications of AI and guiding principles for its usage and develop actionable frameworks for safe and effective implementation that reflect both value and operational burden. Structured as a flexible, ongoing working group, it will adapt to rapid AI evolution and emerging global regulatory frameworks and foster transparency through open collaboration and cross-stakeholder engagement.
Interested? Fill out the form below!
Florence Facilitators

Andrea Bastek
VP of Market Strategy

Sara Saunders
Sr. Manager, Regulatory Affairs


